News | September 20, 2006

Mouse Colon Takes Nikon Small World Award

Nikon Instruments awarded its Small World award to the image of a cell nuclei of a mouse colon as seen through the microscope, which was generated for genomics and bioinformatics research by Dr. Paul Appleton, a researcher from the Division of Cell and Developmental Biology at the University of Dundee in the UK.
Appleton’s image grabbed first place based on its originality, informational content, technical proficiency and visual impact. The image was part of Appleton’s research to understand how cellular changes are regulated and how changes in normal cellular processes contribute to the development of colon cancer.
“Digital microscopy generates tremendous amounts of quantitative information, which is used to measure changes in normal cells,” said Dr. Appleton. “This imaging capability makes an enormous difference in the amount and quality of the information we are able to collect and analyze.”

THE OFFICIAL 2006 NIKON SMALL WORLD WINNERS
The 2006 gallery of winning images can be viewed at www.nikonsmallworld.com.

1st Prize
Dr. Paul L. Appleton
Division of Cell and Developmental Biology
University of Dundee
Dundee, UK
Cell nuclei of the mouse colon (740x)
2-Photon fluorescence

2nd Prize
Raul M. Gonzalez
Raul Gonzalez Estudio
Mexico City, Mexico
Nostoc cyanobacteria and diploneis diatom (100x)
Brightfield

3rd Prize
Jens Rüchel
Department of Zoology
University of Osnabrück
Osnabrück, Germany
Spirorbis sp. (aquatic worm) (100x)
Confocal

4th Prize
Charles J. Kazilek
The Paper Project / W.M. Keck Bioimaging Laboratory
Arizona State University
Tempe, Arizona, USA
Lomandra longifolia (Spiny-headed mat rush) (100x)
Confocal (3-laser)

5th Prize
Dr. Heiti Paves
Tallinn University of Technology
Tallinn, Estonia
Transgenic Nicotiana benthamiana plant (10x)
Fluorescence

6th Prize
Thomas J. Deerinck
National Center for Microscopy and Imaging Research
University of California, San Diego
La Jolla, California, USA
Rat retina astrocytes and blood vessels (160x)
Fluorescence and Confocal

7th Prize
Viktor Sykora
Institute of Pathophysiology
First Faculty of Medicine
Charles University
Prague, Czech Republic
Seed of a Clematis vitalba shrub (also known as Traveller’s Joy and Old Man’s Beard) (2x)
Darkfield

8th Prize
Dr. Carlos A. Munoz
Department of Biology
University of Puerto Rico, Mayaguez Campus
Mayaguez, Puerto Rico
Fluorescing filamentous green alga (60x)
Confocal

9th Prize
Charles B. Krebs
Charles Krebs Photography
Issaquah, Washington, USA
Wing scales of a Urania ripheus (Sunset Moth) (6.25x)
Reflected light

10th Prize
Melissa K. Santala
Department of Materials Science and Engineering
University of California
Berkeley, California, USA
Two m-plane sapphire substrates (100x)
Darkfield

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging

A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging. Graphic courtesy of the Department of Nuclear Medicine, Royal North Shore Hospital, Sydney

News | Prostate Cancer | June 15, 2017
An estimated one in seven American men will be affected by prostate cancer in their lifetime. Prostate-specific...
Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer

IMAGE OF THE YEAR: Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer. Technology of dual-labeled PSMA-inhibitors for PET/CT imaging and fluorescence-guided intraoperative identification of metastases. This work might help to establish a new treatment regimen for more precise and sensitive pre-, intra- and post-therapeutic detection of prostate cancer.

Credit: Courtesy of A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center, Heidelberg, Germany; T. Simpfendörfer, B. Hadaschik, U. Haberkorn, Heidelberg University Hospital, Heidelberg, Germany; PET-image: Afshar-Oromieh et al., EJNMMI 2013; 40(4); STED-image: J. Matthias, German Cancer Research Center.

This study was supported by the VIP+ fund, Federal Ministry of Education & Research (BMBF), Germany.

Scientific Paper 531: “Preclinical evaluation of dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer.” A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center (DKFZ), Heidelberg, Germany; T. Simpfendörfer, B.  Hadaschik, U. Haberkorn, University Hospital, Heidelberg, Germany. Presented at SNMMI’s 64th Annual Meeting, June 10-14, 2017, Denver, Colo.

News | Prostate Cancer | June 15, 2017
In the battle against metastatic prostate cancer, the removal of lymph node metastases using image-guided surgery may...
Axial fused 89Zr-5B1 antibody PET/CT image demonstrates focus of uptake in the liver (arrow). Focus of uptake correlates with increased liver metastasis seen on diagnostic CT (red arrow) performed 2 weeks prior

Axial fused 89Zr-5B1 antibody PET/CT image demonstrates focus of uptake in the liver (arrow). Focus of uptake correlates with increased liver metastasis seen on diagnostic CT (red arrow) performed 2 weeks prior. Image courtesy of Christian Lohrmann, Jason Lewis, Wolfgang Weber, Memorial Sloan Kettering Cancer Center; MabVax Therapeutics

News | PET-CT | June 14, 2017
Pancreatic cancer is associated with bleak five-year survival rates and limited treatment options, but new research is...
PET/CT
News | PET-CT | June 12, 2017
Philips announced that it will be showcasing molecular imaging solutions highlighting Philips’ commitment to innovation...
News | PET-CT | June 12, 2017
Siemens Healthineers has announced that the Food and Drug Administration (FDA) has cleared Biograph Horizon Flow...
Toshiba Medical launches its new Celesteion PUREViSION Edition PET/CT system to help diagnose and treat oncology patients

Toshiba Medical launches its new Celesteion PUREViSION Edition PET/CT system to help diagnose and treat oncology patients.

News | PET-CT | June 09, 2017
Oncologists have access to advanced imaging technologies for excellent cancer patient care with the new Celesteion...
News | SPECT-CT | June 08, 2017
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...
Overlay Init